hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Solution

RxCUI: 1087964
RxNorm name: hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Solution
Display name: hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Solution
Full name: hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Solution
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Hydroxyprogesterone Caproate	HYDROXYPROGESTERONE CAPROATE	Eugia US LLC	687bcf42-f437-42c7-8909-a91f621f55df	2026-06-12	Warnings, Adverse reactions	Exact identifier rxcui: 1087964

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
687bcf42-f437-42c7-8909-a91f621f55df	HYDROXYprogesterone caproate 250 MG/ML Injectable Solution [PSN] · hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Solution [SCD]	2	4	Hydroxyprogesterone Caproate Injection, USP Rx only	20220622
458ed273-ef9c-4351-8bc2-173c3059d107	HYDROXYprogesterone caproate 250 MG/ML Injectable Solution [PSN] · hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Solution [SCD]	2	3	These highlights do not include all the information needed to use HYDROXYPROGESTERONE CAPROATE INJECTION safely and effectively. See full prescribing information for HYDROXYPROGESTERONE CAPROATE INJECTION. HYDROXYPROGESTERONE CAPROATE injection, for intramuscular use. Initial U.S. Approval: 1956	20190418